Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Commissioning delayed

1 Feb 2021 07:00

RNS Number : 4603N
Remote Monitored Systems PLC
01 February 2021
 

1 February 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Remote Monitored Systems plc

("RMS" or the "Company")

Commissioning delayed

 

Remoted Monitored Systems Plc reports that two of the engineers from the Lemu Group ("Lemu"), the manufacturers of the mask manufacturing machine, who are currently working on commissioning the Company's new machine, have tested positive for COVID-19 and are now self-isolating for 10 days. The engineers had not shown any symptoms and had taken the tests as part of the international travel protocols that require airline passengers to have a negative test 72 hours before flying. With commissioning due to have been completed over the weekend, the engineers took their tests on Friday morning, with the positive results received on Saturday morning.

Pharm 2 Farm Ltd ("P2F") have reported the positive tests to BioCity and to Public Health England ("PHE"). Three members of the P2F team have been recorded as close contacts of the Lemu engineers in accordance with PHE Guidelines and will need to self-isolate for 10 days. All the other staff at P2F have undertaken PCR swab tests, with all the tests coming back negative. They can continue working once the unit has been deep cleaned. However, without the Lemu engineers to assist in the completion of the commissioning of the machine, this will now be delayed until after their 10-day quarantine period has ended and they are fit to work.

Antony Legge, Chairman of RMS, said: "It is frustratingly ironic to be so close to the production of an anti-viral mask and to be delayed due to these two positive cases. The lack of symptoms with the two engineers who tested positive shows the importance of following PHE guidelines and serves to further illustrate the market opportunity for our anti-viral masks. Our focus on the health and safety of employees and all visitors to our sites remains our priority and continues to be delivered through well-considered measures."

 

- ENDS -

 

ENQUIRIES:

Remote Monitored Systems plc

Antony Legge (Chairman) via IFC Advisory

Alex Vergopoulos (Executive Director)

 

SP Angel Corporate Finance LLP +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Capital Limited +44 20 7469 0930

Joint Broker

Lucy Williams

 

IFC Advisory Ltd +44 20 3934 6630

Graham Herring

Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUARAAUAOUR
Date   Source Headline
24th Feb 202111:05 amRNSSecond Price Monitoring Extn
24th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:36 pmRNSPrice Monitoring Extension
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20211:00 pmRNSUpdate on commissioning and board changes
12th Feb 20212:05 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 20211:12 pmRNSResult of General Meeting
12th Feb 20217:00 amRNSGeneral Meeting – Link for webinar
9th Feb 20215:56 pmRNSShareholders’ Questions and Answers
8th Feb 20211:23 pmRNSExercise of Options
1st Feb 20211:08 pmRNSExercise of Options
1st Feb 20217:00 amRNSCommissioning delayed
29th Jan 20217:00 amRNSTotal Voting Rights
27th Jan 20217:00 amRNSNotice of General Meeting
26th Jan 20217:00 amRNSExercise of Options
25th Jan 20213:29 pmRNSExercise of Options
25th Jan 20217:00 amRNSExercise of Warrants
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 202112:56 pmRNSEN14683 Certification, Commissioning Update
22nd Jan 20217:00 amRNSShare Option Grant update
21st Jan 20219:06 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 20217:00 amRNSBoard appointment,update on mask production and GM
11th Jan 20216:26 pmRNSDirector Dealing
11th Jan 20217:00 amRNSBoard changes
8th Jan 20215:00 pmRNSDirector Option Exercise and Total Voting Rights
8th Jan 20217:00 amRNSDirector Option Exercise and Total Voting Rights
7th Jan 202110:52 amRNSStatement regarding share price movement
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSPharm 2 Farm Update
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
31st Dec 202011:51 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSPlanned Board Changes & Warrant Update
29th Dec 20207:00 amRNSPharm 2 Farm Update
23rd Dec 20208:13 amRNSUpdate on Fundraising & response to announcements
18th Dec 202011:05 amRNSSecond Price Monitoring Extn
18th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20209:51 amRNSPlacing to raise £5,000,000 and Issue of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.